The FDA acted today on reports that researchers linked several popular antipsychotic drugs with abnormal muscle movements and withdrawal symptoms in newborns.
The FDA mandated new drug labels. They will contain additional and consistent information about the potential risk for abnormal muscle movements. These movements are extrapyramidal signs or EPS. Plus, the label will include withdrawal symptoms in newborns whose mothers used these drugs during the third trimester of pregnancy. The antipsychotic drugs include Haldol, Clozaril, Risperdal, Zyprexa, Seroquel, Abilify, Geodon and Invega.
I encourage all my readers to discuss this new finding with their doctors to minimize any risk that may present in their individual treatment plan.

About the Firm

The Michael Brady Lynch Firm is a trial firm with a focus on pharmaceutical mass tort cases involving SSRI and Anti-Seizure Medication Birth Defects such as Lexapro, Zoloft, Effexor, Prozac, Celexa, Paxil, Depakote and Topamax, as well as Actos Bladder Cancer and Fosamax Femur Fractures, and medical device cases including DePuy Hip and Trans-Vaginal Mesh cases. Contact us today if you or someone you know has experienced side effects involving these products.